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Abstract
The function of Ric-3, which is required for nicotinic acetylcholine receptor (nAChR) expression in
C. elegans, is unclear. Here we found that Ric-3 can promote or inhibit cell-surface delivery of α-
Bungarotoxin-binding nAChRs (BgtRs) composed of α7 subunits. At low levels, Ric-3 promoted
BgtR assembly, endoplasmic reticulum (ER) release and cell-surface delivery without trafficking
from the ER. At high Ric-3 levels, Ric-3 suppressed BgtR surface delivery, but not its assembly, and
BgtRs were retained in the ER or in Ric-3-containing aggregates. In PC12 cells, native BgtRs
trafficked to the cell surface from the ER where low levels of endogenous Ric-3 were observed. In
cultured neurons, native Ric-3 levels were higher than in PC12 cells, and Ric-3 and α7 subunits were
found in somata and dendrites, but not axons, of inhibitory interneurons. Ric-3 trafficked with α7
subunits in rapidly moving vesicles to dendrites where it was restricted to the ER sub-compartment.
We conclude that Ric-3 has two potential functions. At low levels, Ric-3 interactions are short–lived
and promote BgtR assembly and ER release. At higher levels, Ric-3 interactions are longer–lived
and mediate ER retention. In neurons, Ric-3 ER retention appears to promote transport within the
dendritic ER sub-compartment, thereby restricting α7 trafficking to dendrites and preventing axonal
transport.
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Introduction
Nicotinic acetylcholine receptors (nAChRs) are members of the cys-loop family of
neurotransmitter-gated ion channels (Karlin and Akabas, 1995; Albuquerque et al., 2009). The
first neuronal nAChR subtype was identified by its high-affinity α-bungarotoxin (Bgt) binding
(Betz et al., 1982; Conti-Tronconi et al., 1985; Kemp et al., 1985; Whiting and Lindstrom,
1987)Bgt-binding nAChRs (BgtRs) are found on neurons throughout the nervous system at
presynaptic terminals, at postsynaptic sites and extrasynaptic sites and on other non-neuronal
cell types (Wang et al., 2003) (Grando et al., 1996; Sekhon et al., 1999). BgtRs are nAChRs
composed of a single subunit subtype, α7 subunits (Chen and Patrick, 1997; Rangwala et al.,
1997; Drisdel and Green, 2000). Additionally, BgtRs are assembled only in certain cell types
(Blumenthal et al., 1997; Cooper and Millar, 1997; Rangwala et al., 1997) suggesting that they
require cell-specific conditions to properly fold and assemble. Indeed, the palmitoylation of
α7 subunits occurs during BgtR assembly in the ER and is absent in cells unable to assemble
BgtRs (Drisdel et al., 2004). However, cells unable to assemble BgtRs can palmitoylate other
proteins indicating that additional factors help regulate BgtR assembly.
Ric-3 was first identified in C. elegans (Nguyen et al., 1995; Miller et al., 1996) and is required
for nAChR biogenesis and cell-surface expression (Halevi et al., 2002). With reports that Ric-3
promoted (Cheng et al., 2005; Lansdell et al., 2005) or inhibited (Halevi et al., 2003; Castillo
et al., 2005) 5HT3 receptors and α4β2 nAChR surface expression, there is uncertainty about
how Ric-3 affects these receptors. There is also no consensus about the sub-cellular localization
of Ric-3 with most studies finding Ric-3 at ER membranes (Castillo et al., 2005; Cheng et al.,
2005; Wang et al., 2009) but also at the cell surface (Williams et al., 2005) and Golgi apparatus
(Castillo et al., 2005). Studies showing that Ric-3 and receptor subunits co-immunoprecipitate
(Cheng et al., 2005; Lansdell et al., 2005; Williams et al., 2005; Wang et al., 2009) suggest
that Ric-3 chaperones receptor assembly in the ER through long-lived interactions with the
subunits.
Here, we find that Ric-3 activity depended on its expression levels. At low levels, it acted in
the ER to promote α7 subunit assembly and surface delivery. At higher levels, Ric-3 suppressed
α7 surface delivery and retained it in the ER. In PC12 cells, endogenous Ric-3 expression levels
are low and appear to promote α7 subunit assembly and surface delivery. In cultured neurons,
Ric-3 levels are higher than in PC12 cells and Ric-3 is found in the ER of somata and the ER
sub-compartment of dendrites, where it co-localizes with α7 subunits. Our results indicate that
at low levels short-lived interactions with α7 subunits predominated and Ric-3 facilitated BgtR
assembly, ER-release and cell-surface delivery. At higher levels, longer-lived interactions
predominated that retained BgtRs in the ER. In neurons, Ric-3 retained α7 subunits in the ER
sub-compartment of dendrites where they were transported together in vesicles within the ER
sub-compartment. In this way, Ric-3 long-lived interactions preferentially traffic α7 subunits
synthesized in the soma to dendrites instead of axons.
Methods
Cell Culture and Constructs
The human embryonic kidney (HEK) cell line stably transfected with the large T antigen
(tSA201 cells) was from Dr. J. Kyle (University of Chicago, Chicago, IL) and maintained in
DMEM supplemented with 10% calf serum (Hyclone, Logan, UT). The PC12 cell subclone,
PC12 N21 or PC12-C cells (Blumenthal et al., 1997), was from Dr. Richard Burry (Ohio State
University, Columbus, OH). The cells were cultured in DMEM containing 5% heat-inactivated
horse serum and 10% fetal bovine serum (Hyclone). Primary hippocampal neurons were
prepared in the University of Chicago Neuronal Tissue Core using Sprague-Dawley rats at
embryonic day 18 (E18). As previously described (Marks et al., 2000), hippocampi from day
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18 embryos were separated from the diencephalon, dissected free of meninges, and diced.
Hippocampi were digested in 0.1% (wt/vol) trypsin and 0.015% DNAse. After dissociation by
trituration, cells were counted, suspended in plating medium consisting of Neuralbasal-A
supplemented with 2% B-27 (both from Gibco-Invitrogen Corp), 0.5 mM L-glutamine and
0.025 mM L-glutamate. Cells were plated on poly L-lysine-coated 12-mm cover slips at a
density of 8 × 104 cells/cm2. For the live imaging studies, E18 hippocampi were purchased
from BrainBits LLC, (Springfeild, IL) and prepared per manufucaturer’s instructions. All
cultures were maintained at 37°C and 5% CO2. Chick α7 and chick/mouse α7/5HT3A subunit
plasmids were cloned into pMT3 (Rakhilin et al., 1999) and the human Ric-3 cDNA in pcDNA3
was a gift from Dr. Treinin. The fusion of cyan fluorescent protein (CFP) to the N-terminus of
Ric-3 was generated by subcloning Ric-3 into the pECFP-C1 vector (Clontech). An EcoRI site
was inserted just 5’ to the start codon of Ric-3 using the Quikchange site directed mutagenesis
kit (Qiagen). The resulting Ric-3 cDNA was inserted between the EcoRI and SmaI sites of
pECFP-C1. The FLAG epitope (DYKDDDDK) was inserted just after the start codon of Ric-3
using the extension overlap method (Ho et al., 1989). The ER marker, DsRed-ER, was
purchased from Clontech.
Cell Transfections
HEK cell transient transfections (5 µg α7 or α7/5HT3A plasmid, varying amounts of Ric-3
plasmid) were performed using the calcium phosphate method (Eertmoed et al., 1998). The
total plasmid per transfection was 10 µg for a 6-cm plate (p60), with levels adjusted with the
pcDNA3 plasmid. The pMT3 and pcDNA3 plasmids without cDNA insert were used for
control transfections without cDNAs (sham). Neuronal transfections were carried out on 14–
18 days in-vitro cultures using Lipofectamine2000 (Invitrogen) according to manufacturer’s
instructions. Briefly, plasmid and Lipofectamine2000 reagent were mixed in a one-to-one ratio
and complexed in Neuralbasal-A media for 30 minutes. The complex was drop-wise added to
neuronal cultures in 12-well plates and returned to the incubator for 24 hours prior to processing
for immunofluorescence.
125I-Bgt Binding Assays
Intact cells were incubated with 125I-Bgt for 2 hours at room temperature in PBS with 1 mM
EDTA and 10 mM HEPES pH 7.4. For cells expressing α7, 4 nM 125I-Bgt (140–170 cpm/fmol;
PerkinElmer) was used. For cells expressing α7/5HT3A, 125I-Bgt was cut 1 to 9 with cold Bgt
and 100 nM total Bgt was used to avoid depletion of the Bgt. Intact cells were collected, washed
three times with PBS and counted with a LKB-Wallac (Gaithersburg, MD) 1470 automatic
gamma counter. Cells were lysed in Lysis Buffer with Triton (LBT): 150 mM NaCl, 5mM
EDTA, 50 mM Tris, pH 7.4, 1% Triton X-100 supplemented with protease inhibitors (PIs): 2
mM phenylmethylsulfonyl fluoride, 10 µg/ml each of chymostatin, pepstatin, leupeptin, and
tosyl-lysine chloromethylketone, and 50 nM N-ethylmaleimide (NEM). Lysates were
centrifuged at 16000×g and supernatants incubated with 50 µl of concanavalin A-sepharose
slurry (ConA, Sigma Aldrich) for 3 hours at room temperature, which quantitatively
precipitates all (surface plus internal) BgtRs. To measure internal 125I-Bgt binding, 125I-Bgt
binding to cell-surface BgtRs was estimated by ConA-sepharose precipitation after 125I-Bgt
binding to intact cells and solubilization. 125I-Bgt binding to all BgtRs (surface plus internal)
was estimated by incubating the ConA-sepharose precipitated BgtRs again with 125I-Bgt for
2 hours at room temperature. 125I-Bgt binding to internal BgtRs was calculated by subtracting
the cell-surface from the total 125I-Bgt binding. A final estimate of internal 125I-Bgt binding,
adjusted for the loss with ConA pulldown, was made by multiplying by the ratio,
surface 125I-Bgt binding to intact cells: surface 125I-Bgt binding from ConA pulldown. We
determined protein concentrations (mg/ml) from an aliquot of supernatant using the BCA
protein assay (Pierce).
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Western Blots
Cultures were rinsed 3 times with PBS and lysed in LBT with PIs. Insoluble material was
pelleted via centrifugation at 16000×g and the supernatant transferred to a new tube. Protein
concentration was determined by the BCA protein assay (Pierce), and all samples were diluted
to 1 mg/ml. Samples were then reduced with 50 mM TCEP and alkylated with 10 mM NEM
for 30 minutes, then denatured for SDS-PAGE with 5x Laemmli sample buffer. Each lane was
loaded with 200 µg total protein, which was the maximum amount of protein that did not distort
SDS-PAGE and was analyzed on a 8% SDS-PAGE gel which was transferred to a PVDF
membrane and probed with the following antibodies: rabbit anti-actin (1:1000, Sigma), chicken
anti-Ric3 (1:100 (Castelan et al., 2008)), or mouse anti-FLAG-M2 (1:1000, Sigma), goat anti-
α7 (1:100, Santa Cruz), mouse anti-FLAG-M2 (1:1000, Sigma) overnight at 4°C. Membranes
were washed and probed with appropriate fluorescent secondary antibodies (Jackson
Immunocytochemical or Molecular Probes, Invitrogen) for 1 hour at room temperature.
Fluorescence was detected using a Biorad Molecular Imager Pharos-FX which allowed for
quantification using ImageJ (Rasband, 1997–2009).
Flow Cytometry
For surface BgtR labeling, transiently transfected cultures were incubated with 100 nM
Alexa-647-Bgt (Molecular Probes, Invitrogen) for 1 hour at room temperature. The cells were
washed 2x with PBS, incubated in PBS with 10 mM HEPES pH 7.4 and 1 mM EDTA for 15
minutes to gently lift the cells off the plate. Sterile Fluorescence Assisted Cell Sorting (FACS)
was performed with the BD FACSAria using a 405 nm Violet and 633 Red Diode laser. Non-
specific Alexa-647-Bgt binding or autofluorescence was determined by measuring the
fluorescence from sham transfected cultures. Sorting thresholds (gates) were set to collect cells
with fluorescence intensities above those measured from sham transfected cells as illustrated
in Fig. 2. Collected cells were gently centrifuged at 100×g for 5 minutes and resuspended in
regular culture media. 1×105 cells were seeded onto collagen coated coverslips (10 µg/ml) and
allowed to adhere for 12 hours. Cultures were then processed for immunocytochemistry as
described below. Analysis of FACS data was performed using the FlowJo software.
Whole-Cell Patch Clamp Recording
Sterile sorted cells were shipped live via priority overnight delivery to collaborators at Cornell
University. The whole-cell currents were recorded with use of an Axopatch 200A integrating
patch clamp amplifier and Clampex 9 data acquisition software (both from Axon Instruments,
Foster City, CA) as described by Hamill et al. (Hamill et al., 1981). The composition of the
buffer in the recording electrode was 140-mM KCl, 2-mM MgCl2, 1 mM CaCl2, 11 mM
ethylene glycol-bis(β-aminoethyl ether)-N, N, N′, N′-tetraacetic acid (EGTA), and 25 mM N-2-
hydroxyethylpiperazine- N′-2-ethanesulfonic acid (HEPES), adjusted to pH 7.4 with KOH.
The composition of the extracellular (bath) buffer was 145 mM NaCl, 3-mM KCl, 2 mM
MgCl2, 1 mM CaCl2, and 25 mM HEPES, adjusted to pH 7.4 with NaOH. Recording electrodes
were pulled from borosilicate glass capillaries on a PIP5 two-stage vertical pipette puller
(HEKA Elektronik, Lambrecht / Pfalz, Germany), and the electrode resistance was typically
2–3 MΩ. The series resistance was typically 3–5 MΩ, and was up to 70% compensated
electronically. All measurements were carried out at room temperature (22–24 °C) and a
membrane potential of − 60 mV. 1 mM ACh-Cl dissolved in the extracellular buffer was applied
for 0.2 s using cell-flow technique (Udgaonkar and Hess, 1987). Data were low-pass filtered
at 2 kHz (4-pole Bessel filter) and digitized at 5 kHz.
Immunocytochemistry
For cell surface BgtR labeling, live cultures were incubated with 100 nM fluorescent Bgt
(Molecular Probes, Invitrogen) for 30 minutes at 37°C. To block surface BgtRs for labeling of
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internal BgtRs, live cultures were incubated with 100 nM unlabeled Bgt for 30 min at 37°C.
Cultures were washed 3 times with culture medium then processed as follows. Cells were fixed
in 2% paraformaldehyde with 75 mM Lysine and 10 mM periodate in PBS (PLP) for 10
minutes, quenched with 100mM Glycine for 10 minutes, and permeabilzed with 0.5% Triton
X-100 for 10 minutes. Blocking of non-specific sites was performed with 5% Normal Donkey
Serum (NDS) and 0.1% fish gelatin in PBS for 1 hour prior to incubating with primary
antibodies in blocking solution overnight at 4°C. Antibodies and dilutions used were: Anti-
PDI at 1:2500 (ABR), anti-GM130 at 1:300 (BD Transduction Labs), fluorescent bungarotoxin
(100 nM, Molecular Probes), anti-α7 (1:100, Santa Cruz), anti-Ric-3 (1:100, (Castelan et al.,
2008)), anti-MAP2 (1:1000, Cell Signaling Technology), anti-NFH (1:1000, Aves Labs), anti-
GAD (1:1000, Chemicon). Cells were then incubated in appropriate secondary antibodies as
described in figure legends (1:1000) for 1 hour at room temperature. In some cases, nuclei were
labeled with Hoechst dye for 5 minutes. Cells were mounted in ProLong gold and allowed to
cure for 24 hours prior to imaging on either the Olympus DSU spinning disk or Leica SP-5
scanning laser confocal microscope (Integrated Microscopy Facility, University of Chicago).
To facilitate quantitative fluorescence measurements, care was taken so that microscope
settings were set below saturating fluorescence intensities. To estimate background
fluorescence samples were prepared without primary antibody or, in the case of Bgt, by
including 1 mM nicotine for 5 minutes before and during FL-Bgt labeling in the presence of
1 mM nicotine.
Image Analysis
In supplemental Fig. 2, sorted HEK cells were judged as containing CFP-Ric-3 aggregates if
the cells contained one or more large aggregates or two or more smaller aggregates. To estimate
the amount of Ric-3 or Fl-Bgt labeling in PC12 cells and neurons preference was given to
isolated cells. Each cell was circled using ImageJ software and the total fluorescence for each
slice of a confocal stack was estimated and summed. To estimate the intensity of Fl-Bgt puncta,
we measured the fluorescence intensity of n puncta, averaged the data and compared it to
fluorescence intensity measurements of a same size region within 1 µm of the puncta. To
estimate the size of Fl-Bgt puncta, the number of pixels through the center of the puncta was
determined, and the corresponding pixel size used to calculate the diameter (0.16 µm per pixel
at 100x). In Fig. 5G, sorted HEK cells were judged as containing Fl-Bgt puncta if they contained
4 or more Fl-Bgt puncta. In all cases, background fluorescence was determined by performing
an identical analysis on cells labeled in the absence of primary antibody or, for Fl-Bgt imaging,
labeled in the presence of nicotine as described above. When necessary, randomly sampled
images were acquired by choosing fields of view using DIC.
Degree of Colocalization Estimations
For colocalization analysis of confocal stacks, we used the ImageJ Intensity Correlation
Analysis plug-in (Li et al., 2004). Images were first deconvolved using the Huygens Pro
deconvolution software (SVI Inc). Individual cells were carefully outlined (including dendrites
if analyzing neurons) and cropped, pixel intensities normalized to maximum intensity for each
fluorophore and the resulting confocal stack was then processed by the Intensity Correlation
Analysis plug-in. The frequency scatter plot generated is used to illustrate the extent of
colocalization and the Mander’s overlap coefficient as was determined from at least 10 cells
used to test for significance.
Statistical Analysis
Results are expressed as mean ± standard error of the mean (SEM) of n samples. Statistical
significance was assessed by a two-tailed Student’s t-test or ANOVA as appropriate using
Microsoft Excel.
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Results
Ric-3 promotes and inhibits BgtR cell-surface delivery
To investigate the effects of Ric-3 on BgtR formation in more detail, we varied the amount of
human Ric-3 plasmid transfected with either the α7 subunit or a chimeric subunit composed
of the N-terminal half of α7 and the C-terminal half of 5HT3A subunits (α7/5HT3 subunits)
(Fig. 1). Unlike the α7 subunit, the α7/5HT3 subunit does not require Ric-3 to form BgtRs in
HEK cells (Eisele et al., 1993;Rangwala et al., 1997). We compared the effects of Ric-3 on
BgtR formation and cell-surface expression by measuring intracellular and surface 125I-Bgt
binding to α7 (Fig. 1A) or α7/5HT3 BgtRs (Fig. 1B). Intracellular 125I-Bgt binding to α7 BgtRs
increased 5-fold over the whole range of transfected Ric-3 plasmid. In contrast, cell-surface
expression peaked with a 40-fold increase at much lower levels of Ric-3 plasmid and declined
to a 12-fold increase at higher levels of Ric-3 plasmid. Levels of intracellular 125I-Bgt binding
to α7/5HT3 chimeric BgtRs were independent of transfected Ric-3 plasmid and cell-surface
expression was unaffected at lower levels of Ric-3 plasmid and showed a steep decline at the
higher levels of Ric-3 plasmid (Fig. 1B). Ric-3 protein levels were assayed by immunoblots
using FLAG-tagged Ric-3 (Fig. 1C) and there was no difference between FLAG-tagged and
untagged Ric-3 with respect to how varying Ric-3 plasmid affected BgtR cell-surface
expression (data not shown). Ric-3 levels rose linearly with increasing transfected plasmid
amounts in the range in which FLAG-Ric-3 protein was detectable (corresponding to 0.01 to
2.5 µg Ric-3 plasmid). Ric-3 protein levels are a linear function of transfected plasmid below
2.5 µg, whereas above 2.5 µg transfected plasmid, Ric-3 protein levels saturated. We examined
a generic membrane protein, CD8α, and found its surface expression was unaltered by high
Ric-3 levels (supplemental Fig. 1), which indicates that the decline in surface 125I-Bgt binding
we observed at high Ric-3 levels was specific to α7 and α7/5HT3 BgtRs and not a general
effect of Ric-3 on membrane protein trafficking.
We have previously observed that Bgt binding sites form on α7 and α7/5HT3 chimeric BgtRs
during subunit assembly in the ER and that intracellular 125I-Bgt binding is a measure of the
amount of newly assembled BgtRs prior to surface insertion (Rakhilin et al., 1999; Drisdel et
al., 2004). The increased number of intracellular α7 BgtRs with Ric-3 levels (Fig. 1A), thus,
indicates that Ric-3 enhances Bgt site formation and α7 BgtR assembly in the ER. There was
no effect of varying Ric-3 levels on the levels of α7 subunit protein, which remained constant
over the range of Ric-3 tested (data not shown). In contrast to α7 BgtRs, there was no change
in intracellular α7/5HT3 BgtRs with Ric-3 levels (Fig. 1B) from which we conclude that Ric-3
has little to no effect on α7/5HT3 BgtR assembly. The lack of a Ric-3 effect on α7/5HT3 Bgt
site formation could be explained if the levels of α7/5HT3 BgtRs assembled were already at
saturating levels in the absence of Ric-3. This is consistent with the observation that ~50% of
the total α7/5HT3 BgtRs are expressed on the cell surface in the absence of Ric-3 and that at
peak surface expression of α7 BgtRs with Ric-3 co-expression, 45% of the total α7 BgtRs are
also expressed on the cell surface (Fig. 1D) suggesting that the cell is at its maximum capacity
for expressing surface BgtRs in relation to the total number available.
Ric-3 appears to have two separate actions on α7 subunits. The first effect is observed at low
Ric-3 levels (0 to 0.1 µg plasmid) where there is an increase in subunit assembly into BgtRs
as well as increased α7 BgtR forward trafficking. This effect is caused by increased BgtR
assembly that, in turn, increased the rate of the forward trafficking. These effects occur at such
low levels of Ric-3 plasmid (Fig. 1A) and protein (Fig. 1D) that the interactions between Ric-3
and α7 subunits are very far from stoichiometric. For such a small amount of Ric-3 to alter
much larger amounts of α7 subunits, the data indicates that the interaction between Ric-3 and
α7 subunits causing these effects is short lived. The third effect is observed at higher Ric-3
levels (0.1 to 5.0 µg plasmid), where Ric-3 blocked BgtR insertion at the cell surface for α7
and α7/5HT3 BgtRs. Because Ric-3 only inhibited cell-surface and not intracellular BgtR
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levels, Ric-3 appears to block BgtR forward trafficking to the cell surface without altering its
actions on BgtR assembly. Because these effects occur when Ric-3 and subunit plasmid levels
are approximately equal, interactions between Ric-3 and the subunits may be much much
longer lived and may act to sterically retain the subunits within a compartment in the cells. A
longer-lived interaction between Ric-3 and the subunits is indicated by our ability (data not
shown) and others (Cheng et al., 2005;Williams et al., 2005;Wang et al., 2009) to co-
immunoprecipitate Ric-3 and the subunits at the higher Ric-3 levels.
Ric-3 alters BgtR cellular distribution and localization
To further address how Ric-3 affects BgtR expression, we examined their distribution at the
single-cell level using fluorescence microscopy. From the outset, we found that the cell-to-cell
variations resulting from transient transfection of the constructs made it difficult to analyze the
experiments. Also, antibodies (Abs) generated against the Ric-3 C-terminal cytoplasmic
domain (Castelan et al., 2008) could not reliably detect Ric-3 transfected with 0.01 µg plasmid
or less. To address these problems, we generated a fluorescent Ric-3 construct tagged with
cyan fluorescent protein (CFP) at its N-terminus (CFP-Ric-3) and used fluorescence-based
flow cytometry to select cells for immunofluorescence microscopy. This strategy isolated more
uniform populations of cells in terms of surface BgtR and Ric-3 expression. To assay BgtRs
on the cell surface with cell sorting, BgtRs were stained with fluorescently labeled Bgt (Fl-
Bgt). With the addition of the CFP tag, Ric-3 reduced α7 subunit synthesis when transfected
higher then at 0.1 µg plasmid (data not shown). We avoided reduced α7 subunit synthesis by
using a mixture of CFP-tagged (no more than 0.1 µg) and untagged Ric-3 for transfections
with Ric-3 plasmid levels greater than 0.1 µg (data not shown). The CFP-tagged Ric-3 had the
same cellular distribution as the untagged Ric-3 when co-transfected at both low and high levels
of total Ric-3 (supplemental Fig. 2A).
We performed cell sorting on three sets of transfected cells. One set of cells was sorted from
cells expressing α7 subunits and no Ric-3 (Fig. 2A–C). Results from the cell sort are displayed
in Fig. 2A where each point represents single-cell fluorescence values for surface Fl-Bgt (y-
axis) and, in this case CFP (x-axis). Very few cells had significant Fl-Bgt staining on the cell-
surface consistent with the 125I-Bgt staining of the cells (Fig. 1A). This result was verified
using immunofluorescence microscopy on the sorted cells (Fig. 2B). Because of a lack of Fl-
Bgt staining, cells were co-transfected with a CFP plasmid to help select for cells that contain
α7 subunits without Fl-Bgt staining. There was a high degree of α7 and CFP co-expression
(92.3% ± 0.3%, n=3 fields of view, 119 cells total) in cultures transfected with α7 and CFP
plasmid (Fig. 2B,C). Another set of cells was sorted from cells expressing α7 subunits and low
levels of Ric-3 (Fig. 2D–F). As expected, large numbers of these cells were stained for Fl-Bgt
(89.5% ± 1.5%, n=3 fields of view, 137 cells total) yet most cells lacked levels of CFP-Ric-3
fluorescence detectable by the flow cytometer (Fig. 2D). Because so few cells with α7 alone
expressed detectable levels of surface BgtR, the cells co-transfected with CFP-Ric-3 exhibiting
surface Bgt staining must express some CFP-Ric-3 even though most of them (95%) had CFP
fluorescence undetectable by the flow cytometer. CFP-Ric-3 fluorescence was detectable in a
higher percentage of the cells using a fluorescent scanning microscope (19.5% ± 3.1% of n=3
fields of view, 190 cells total) as shown in Figs. 2E and F. Displayed in Fig. 2E are two cells
that are surface stained with Fl-Bgt. One cell was positive for CFP-Ric-3 fluorescence and in
the other cell CFP-Ric-3 fluorescence was undetectable as observed for most cells. These
results provide further evidence that the Ric-3 levels that mediate α7 BgtR assembly and surface
delivery are extremely low such that they are often undetectable by immunoblot (Fig. 1C),
flow cytometry (Fig. 2D) or by fluorescent microscopy measurements (Fig. 2E). In the cells
positive for Fl-Bgt and CFP-Ric-3 fluorescence, there was no detectable overlap of CFP-Ric-3
and surface Fl-Bgt fluorescence (e.g., Fig. 2E, inset). This finding indicated that little to no
Ric-3 trafficked with α7 BgtRs to the cell-surface or that Ric-3 was rapidly internalized once
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it arrived at the cell surface. In cells with detectable levels of CFP-Ric-3 fluorescence, Ric-3
was diffusely distributed throughout much of the cell with a perinuclear and reticulated pattern
typical of the ER.
A final set of cells was sorted from cells expressing α7 subunits and high levels of Ric-3 (Fig.
2G–I). At high Ric-3 levels, the number of Fl-Bgt positive cells was reduced (Fig. 2G),
consistent with the decrease in surface 125I-Bgt binding observed at high Ric-3 levels (Fig 1A).
Cells lacking surface Fl-Bgt tended to have significant CFP-Ric-3 fluorescence and we sorted
for the cells that were positive for CFP-Ric-3 and lacked Fl-Bgt (boxed area in Fig. 2G). An
example typical of this cell population is displayed in Figs. 2H and I. The distribution of Ric-3
and α7 subunits in these cells was different from cells with lower Ric-3 expression. In addition
to a diffuse distribution of Ric-3 and α7 subunits throughout the cells, there were round
aggregated structures with hollow centers (see inset in Fig. 2H). Similar aggregated structures
were observed previously with heterologous expression of Ric-3 (Castillo et al., 2005; Cheng
et al., 2005; Wang et al., 2009). To further analyze Ric-3’s cellular distribution, we determined
the number of cells with aggregates as in Figs. 2H and I, or free of aggregate as in Figs. 2E
and F. We did not find any aggregates at low Ric-3 levels when cells were positive for surface
Fl-Bgt staining (supplemental Fig. 2). At high Ric-3 levels, 70–80% of the Bgt positive cells
had aggregates and 20–30% of the cells lacked them (supplemental Fig. 2C). Thus, aggregates
of Ric-3 and α7 subunits were observed in cells with high Ric-3 levels in which BgtRs were
transported to the cell surface suggesting that the aggregates alone are not totally responsible
for inhibiting surface delivery of BgtRs, or, that the aggregates formed subsequent to surface
delivery of BgtRs. In cells with no significant Bgt staining (supplemental Fig. 2D), Ric-3
aggregates were observed at all levels of Ric-3 expression together with a diffuse distribution
of Ric-3. Ric-3 aggregates were even observed at the lower levels of Ric-3 expression
suggesting that in a small population of these cells Ric-3 levels were high enough so that
aggregates formed.
Ric-3 regulation of α7 BgtR function
Previous studies have found increased numbers of functional α7-containing BgtRs with the
addition of Ric-3 to the cells but did not test whether the increase varied with changes in Ric-3
levels. To address this question, we performed whole-cell patch clamp recordings on sorted
cells transfected with α7 and varying levels of Ric-3 plasmid (Fig. 3). Sorted cells positive for
Fl-Bgt staining generally displayed rapidly desensitizing ACh-evoked currents, a feature of
α7 nAChRs. An example is displayed in the inset in Fig. 3. We observed no ACh-evoked
currents from cells without significant Fl-Bgt staining. As shown in Fig. 3, the frequency of
observing a response (19 out of 25 cells) and mean amplitude was significantly larger for cells
with low Ric-3 levels than for cells with high levels of Ric-3 (8 out of 15 cells). Cells with
α7 subunits but no Ric-3 did have ACh-evoked currents, but the frequency of the responses (9
out of 16 cells) and their mean amplitude was significantly smaller than for cells at the two
Ric-3 levels. From these measurements, we conclude that the number of functional receptors
has the same dependence on Ric-3 levels as the number of cell-surface BgtRs as determined
in Figs. 1 and 2 using 125I-Bgt or Fl-Bgt.
Cellular localization of Ric-3 in the absence of α7 subunits
Contrary to a previous report (Williams et al., 2005), we did not observe co-localization
between Ric-3 and surface BgtRs (Fig. 2E). Ric-3 was also reported in the Golgi complex
(Castillo et al., 2005) as well as in the ER (Castillo et al., 2005; Cheng et al., 2005; Wang et
al., 2009). In Fig. 4, we tested whether Ric-3, in the absence of α7 subunits, is predominantly
in the ER or at other sites along the secretory pathway such as the Golgi complex. Cells with
high or low Ric-3 levels and no α7 subunits were sorted using CFP-Ric-3 fluorescence to isolate
a more homogenous population of cells containing different Ric-3 levels. These cells were
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stained with an ER marker (protein disulfide isomerase (PDI) specific Ab), or a Golgi marker
(GM-130 specific Ab). At the low Ric-3 levels, CFP-Ric-3 co-localized strongly with the ER
marker and little to none with the Golgi marker (Fig. 4A). We gauged the degree of
colocalization by comparing the intensities of the two fluorophores pixel by pixel in the
confocal images (see supplemental Fig. 3 for details). The degree of linear correspondence
between the CFP-Ric-3 fluorescence and that of the ER marker was determined (see
supplemental Fig. 3) from which we obtained a Manders coefficient (Manders et al., 1992), R
with values from 1 (perfect overlap) to 0 (no overlap). 86% of the CFP-Ric-3 pixels co-localized
with those of the ER marker (R = 0.66 ± 0.1, n=10 cells, supplemental Fig. 3B) indicating
strong co-localization. In contrast, no significant co-localization between CFP-Ric-3 and the
Golgi marker was found as shown by the lack of correspondence between the CFP-Ric-3
fluorescence and that of the Golgi marker (Fig. 4C). Only 2% of the CFP-Ric-3 pixels
overlapped with the Golgi marker and 6% of the Golgi marker pixels overlapped with CFP-
Ric-3 pixels (R = 0.12 ± 0.03, n=10 cells, supplemental Fig. 3B). Thus at low Ric-3 levels,
Ric-3 is predominantly localized in the ER and not in the Golgi or at the cell-surface.
At high levels of Ric-3 (Fig. 4D,E,F), the Ric-3 distribution changed and we observed
aggregated structures just like when Ric-3 was co-expressed with α7 subunits (Fig. 2F,I).
Together with a lack of α7 subunit aggregates in the absence of Ric-3, this finding, demonstrates
that Ric-3 mediates aggregate formation. The Ric-3 that was not within aggregates co-localized
with the ER marker (Fig. 4D). Many of the aggregated Ric-3 structures, however, did not co-
localize with the ER marker while others did co-localize partially or co-localized completely
(Fig. 4E). Consistent with this observation, we measured less (65%, R = 0.47 ± 0.05, n=10
cells, supplemental Fig. 3F) of the CFP-Ric-3 overlap with the ER marker as compared to 86%
overlap with low-levels of Ric-3. Again, there was no significant overlap of CFP-Ric-3 with
the Golgi marker (1%, R = 0.07 ± 0.01, n=10 cells, Fig. 4F and supplemental Fig. 3F). The
results suggest that the aggregation initially occurs in the ER and later departs.
Effects of Ric-3 levels on α7 subunit and BgtR localization
We performed additional experiments to examine whether Ric-3 altered the subcellular
distribution of α7 subunits or vice-versa. Cells were transfected with α7 subunit plasmid and
no, low (0.01 µg) or high (5 µg) levels of Ric-3 plasmid and sorted using flow cytometry as in
Fig. 2. The distribution of α7 subunits in the absence of Ric-3 was examined using anti-α7 Ab
staining (Fig. 5A) and found to co-localized with the ER marker as has been previously
observed (Cooper and Millar, 1997). The distribution of α7 co-expressed with low levels of
Ric-3 was assayed using CFP-Ric-3 and is displayed in Fig. 5C and the inset. There was strong
overlap between Ric-3, α7, and the ER marker consistent with ER localization when Ric-3
increases BgtR surface delivery (Fig. 1A). As in Fig. 2, we did not observe any significant co-
localization of Ric-3 with the Golgi marker (data not shown) suggesting that Ric-3 again does
not traffic with BgtRs out of the ER.
We used Fl-Bgt staining to assay the more mature, Bgt-binding pool of intracellular receptors.
Surface BgtRs were excluded by binding surface BgtRs on intact cells with unlabeled Bgt prior
to permeabilizing the cells. Bgt binding sites form on α7 subunits as they assemble into
functional BgtRs in the ER (Rakhilin et al., 1999; Sweileh et al., 2000; Drisdel et al., 2004).
Thus, Fl-Bgt should stain the pool of BgtRs assembling in the ER and a second pool of BgtRs
that are released from the ER and trafficked to the cell surface. As expected, we did not detect
Fl-Bgt staining in cells expressing α7 subunits without Ric-3 (Fig. 5B), conditions in which
few to no BgtRs are assembled (Fig. 1A). At low levels of Ric-3, some of the intracellular Fl-
Bgt staining coincided with the ER marker (Fig. 5D) just like the staining with anti-α7 Ab (Fig.
5C). These Fl-Bgt stained receptors were diffuse and of relatively weak intensity, consistent
with a pool of intracellular BgtRs that are still assembling in the ER. In addition, Fl-Bgt stained
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punctate structures throughout the cytoplasm (Fig. 5D and G). The size and shape of the
punctate structures (diameter between 0.3 and 0.7 mm, n=20) were consistent with transport
vesicles, in which the BgtRs had a higher fluorescence intensity (2.9 ± 0.3 fold, n=7 cells, 32
puncta) than the Fl-Bgt in the ER and, thus, 3-fold higher density (Fig 5D and inset). There
was little co-localization between the punctate Fl-Bgt-stained structures and CFP-Ric-3, the
ER (Fig. 5D) or Golgi markers (data not shown), consistent with these BgtR-containing
structures being transport vesicles released from the ER and/or Golgi with BgtRs at a higher
density.
To further test whether the Bgt-stained puncta had features expected of transport vesicles, we
analysed whether the Bgt-stained puncta correlated with the surface delivery of BgtRs as a
function of varying Ric-3 levels. In Fig. 5G we plotted the number of sorted cells with four or
more Bgt-stained puncta at the different levels of Ric-3. Significant numbers of cells with Bgt-
stained puncta were only observed in cells sorted for surface Fl-Bgt staining (Fl-Bgt+) at the
different Ric-3 levels. Puncta were not observed in the absence of Ric-3 expression or for cells
with no significant surface Bgt staining and positive for CFP-Ric-3 fluorescence. We
previously reported the presence of Bgt-stained puncta in cells with α7/5HT3 BgtRs (Drisdel
et al., 2004). Examples of these α7/5HT3 BgtR puncta are also displayed in supplemental Figs.
4A and B. In contrast to α7 BgtRs, α7/5HT3 BgtRs form and traffic to the cell surface very
efficiently in the absence of Ric-3. Additionally, the surface and intracellular levels of α7/5HT3
BgtRs are much higher than that obtained with α7 BgtRs and low levels of Ric-3 do not affect
the surface expression of α7/5HT3 BgtRs (Fig. 1B). We performed cell sorting and
immunostaining experiments in which α7/5HT3 was transfected with or without low levels of
CFP-Ric-3 (supplemental Figs. 4A and B). We found that in the absence or presence of low
levels of CFP-Ric-3 virtually every cell contained Bgt-stained puncta. These findings are
different from that with α7 BgtRs where no puncta were observed in the absence of Ric-3 and
at best only ~40% of the cells had Bgt-stained puncta (Fig. 5G). Thus, for both α7 and α7/5HT3
BgtRs, the number of cells positive for Bgt-stained puncta correlates well with the levels of
surface BgtR expression, another indication that the puncta are transport vesicles. Altogether
the data are consistent with Ric-3, at low levels, facilitating the formation of BgtRs in the ER.
Ric-3 may also help mediate the entry and increased density of BgtRs at ER release sites, where
their exit in transport vesicles occurs. However, Ric-3 does not appear to enter the vesicles
with the BgtRs as they traffic to the cell surface.
We also examined how high levels of Ric-3 altered BgtR localization (Fig. 5E and F). A
significant change observed with high Ric-3 levels was the loss of surface delivery of BgtRs
(Figs. 1 and 2) and loss of the BgtR-containing small puncta observed with low Ric-3 levels
(Fig. 5G). Many of the aggregated structures observed with high levels of Ric-3 were stained
with anti-α7 Abs (Fig. 5E and inset) and with Fl-Bgt (Fig. 5F). We observed a similar change
in the distribution of α7/5HT3 BgtRs in the presence of high levels of Ric-3 (supplemental Fig.
4C). In addition to the aggregates, we observed significant levels of anti-α7 Ab and Fl-Bgt
staining diffusely co-localized with Ric-3 in the ER of these cells. We estimated the total
cellular Fl-Bgt and that portion that co-localized with the aggregates 36 hours after transfection
when surface 125I-Bgt binding peaked. At this time, we found that 67% of BgtRs were in the
aggregates and 33% of BgtRs were not aggregated and were diffusely distributed with Ric-3
in the ER. One possibility is that BgtRs associate with aggregated Ric-3 and this association
retains BgtRs in the ER reducing the amount of BgtRs available for surface transport. Because
at high Ric-3 levels so few of the intracellular BgtRs arrive on the cell surface (~10% of α7
BgtRs; Fig. 1) despite a significant pool of diffuse BgtRs, another possibility is that the diffuse
Ric-3, not the aggregated Ric-3, retains BgtRs in the ER. Many of the aggregated structures
that contain Ric-3 and α7 subunits do not co-localize with the ER marker (Fig. 4D and E)
consistent with the structures moving out of the ER. These data suggest that Ric-3 at high levels
prevents BgtRs assembled in the ER from entering transport vesicles and retains BgtRs in the
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ER. Retained BgtRs complexed with Ric-3 subsequently aggregate and the aggregates
somehow depart the ER.
Native Ric-3 in PC12 cells
To further investigate the relationship between Ric-3 levels and BgtR expression, we assayed
Ric-3 in cells with endogenous Ric-3 and BgtRs. We first examined the rat pheochromocytoma
cell line, PC12 (N21 variant (Blumenthal et al., 1997; Rangwala et al., 1997)), to assay the
levels of endogenous Ric-3 and compare its distribution relative to that of endogenous α7
subunits. The levels of α7 BgtRs on the surface of PC12 cells (~0.15 pmol/mg, data not shown)
were somewhat less than the peak levels we observed in HEK cells co-expressed with α7
subunit and Ric-3 plasmids (Fig. 1A). Ric-3 mRNA is found in PC12 cells (Williams et al.,
2005), but we were unable to detect Ric-3 by immunoblot analysis with similar levels of total
cellular protein (data not shown). This finding indicates that the levels of Ric-3 in PC12 cells
are less than what we obtained with heterologous expression in the range of 0.05 to 0.01 µg
Ric-3 plasmid (Fig. 1C). To confirm the presence of Ric-3 mRNA in our PC12 cells, we
performed RT-PCR and observed a band at the expected size for rat Ric-3 (data not shown).
We observed immunostaining of the PC12 cells with Ric-3-specific Abs (Fig. 6A) not observed
with a pre-immune serum control (data not shown). The pattern and levels of staining were
similar to that observed in 20% of HEK cells with low levels of Ric-3 (Fig. 2E, H) consistent
with the presence of the Ric-3 protein in the PC12 cells. As assayed by immunofluorescence,
Ric-3 was present in virtually all PC12 cells (Fig. 6A), co-localized with α7 subunits, and varied
in expression levels over a 2-fold range (Fig. 6B). The ability of the Ric-3 Ab to stain the PC12
cells but not the corresponding immunoblots suggested that the Ric-3 Ab affinity is dependent
on the epitope conformation.
Based on several observations, the levels and distribution of Ric-3 in PC12 cells were similar
to that seen in HEK cells expressing low levels of Ric-3. First, increasing levels of Ric-3
correlated with increased levels of surface and internal BgtRs as assayed by Fl-Bgt staining
(Fig. 6B) similar to what we observed with low levels of Ric-3, but not for high levels of Ric-3,
in the HEK cells (Fig. 1A). As observed in the HEK cells, none of the Ric-3 staining in the
PC12 cells co-localized with the surface Fl-Bgt staining (Fig. 6C). Second, Ric-3 had a diffuse,
perinuclear distribution in the PC12 cells that was highly co-localized with ER markers as well
as with α7 subunits (Fig. 6D), consistent with an ER localization. None of the Ric-3 aggregation
observed with high levels of Ric-3 in HEK cells was observed in the PC12 cells. Third, with
Fl-Bgt intracellular staining we also observed two pools of intracellular BgtRs (Fig. 6E) similar
to that observed in HEK cells. The first pool was diffuse, of weaker intensity and highly co-
localized with Ric-3 staining. The second pool were in puncta with the features of transport
vesicles in that the Fl-Bgt staining did not co-localize with Ric-3 or ER staining and had a 3-
fold higher fluorescence intensity than the first pool (3.2 ± 0.3 fold, n=10 cells, 61 puncta; Fig
6E).
Ric-3 and α7 subunits in neurons
We also examined native Ric-3 in primary cultures of rat hippocampal neurons and compared
its distribution to that of α7 subunits. Previous studies found that 60 – 100% of the GABAergic
interneurons in neuronal cultures contain α7 subunits (Liu et al., 2001; Kawai et al., 2002),
which are 7 to 15% of the total neurons. These finding are consistent with results from slices
and sections taken from adult hippocampi where it was observed that 125I-Bgt binding sites
and functional BgtRs are found predominantly on GABAergic interneurons (Jones and Yakel,
1997; Frazier et al., 1998; Albuquerque et al., 2009). We observed a similar distribution of
α7 subunits and GABAergic neurons in our cultures using staining for glutamic acid
decarboxylase (GAD; see Table 1). As shown in Fig. 7A and Table 1, there is a strong
correspondence between neurons that stain for Fl-Bgt, Ric-3 and anti-GAD. Furthermore, like
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α7 subunits (Kawai et al., 2002; Xu et al., 2006), Ric-3 is restricted to somata and dendrites,
as shown by its co-localization with microtubule-associated protein 2 (MAP2), and is not found
in axons as shown by a lack of co-localization with neurofilament heavy chain (NFH) in axons
(Fig. 7B). As in PC12 cells, Ric-3 closely co-localized with the ER marker. In somata (Fig.
7C), the staining was similar to the perinuclear distribution seen in PC12 cells and HEK cells
with low levels of Ric-3. There was also a high degree of co-localization between Ric-3 and
α7 (Fig. 7D) in the ER as in PC12 and HEK cells. Much of the Fl-Bgt in somata was diffuse
and co-localized with Ric-3 (Fig. 7E) in the ER. Fl-Bgt puncta with 3-fold higher fluorescence
intensity (3.3 ± 0.3 fold, n=6 cells, 27 puncta; Fig. 7E inset) were also observed. There may
have been some co-localization between the Fl-Bgt puncta and Ric-3 in the perinuclear region
but we believe that this was caused by the close proximity of the Fl-Bgt puncta, which appear
to be transport vesicles. Fl-Bgt puncta that we observed further from the ER in somata clearly
showed no co-localization with Ric-3 (Fig. 7E, inset).
As with PC12 cells, the expression levels of Ric-3 in the somata of the neurons varied over a
2-fold range. Levels of Ric-3 in neurons were significantly higher than in PC12 cells yet there
were no signs of Ric-3 aggregation as was observed with higher levels in HEK cells. Compared
to the levels of Ric-3 in PC12 cells (1.0 ± 0.06 fold, n=67 cells), Ric-3 levels in neurons were
approximately 3-fold higher (2.8 ± 0.11 fold, n=94 cells; p<0.001). Because Ric-3 is restricted
to the ER as in HEK and PC12 cells, we were initially surprised by the levels of Ric-3 in the
dendrites. However, in dendrites Ric-3 co-localizes with the ER marker in the shafts (Fig. 7F)
consistent with Ric-3 present in the ER sub-compartment that exists throughout dendrites
(Bannai et al., 2004;Mironov and Symonchuk, 2006). α7 subunits are found throughout the
dendrites and co-localized with Ric-3 (Fig. 7G) in the ER sub-compartment. To label
intracellular receptors with Fl-Bgt, surface BgtRs were blocked with unlabeled Bgt. We found
brightly stained Fl-Bgt puncta throughout the dendrites (Fig. 7H), which did not co-localize
with Ric-3 or the ER marker. There was also weak and diffuse Fl-Bgt staining in the shafts
that appeared to co-localize with Ric-3.
To better visualize Ric-3 in neurons, we transfected neurons with CFP-Ric-3 (Fig. 8). Most
transfections of CFP-Ric-3 did not significantly increase total Ric-3 above normal levels, and
CFP-Ric-3 showed a diffuse reticulated pattern in the somata similar to endogenous Ric-3 and
co-localized in the ER (Fig 8A, left). When CFP-Ric-3 was transfected at higher levels, we
occasionally observed aggregates indicating that we were over-expressing Ric-3 as observed
in HEK at high levels (Fig. 8A, right). At the lower levels, CFP-Ric-3 was distributed in the
somata and dendrites but not in axons (Fig. 8B) indicating that at these levels CFP-Ric-3 had
the expected distribution. Furthermore, transfection of CFP-Ric-3 did not significantly
interfere with the assembly and surface transport of native BgtRs as shown by strong surface
Fl-Bgt staining of endogenous BgtRs in transfected neurons (Fig. 8C). As observed in PC12
and HEK cells, none of the Ric-3 colocalized with surface Fl-Bgt staining (Fig. 8C inset).
In the somata, CFP-Ric-3 co-localized with transfected α7-HA subunits in the ER labeled by
DsRed-ER (Fig. 8D). We only analyzed transfected GABAergic interneurons by anti-GAD
immunostaining (not shown). In dendrites, CFP-Ric-3, α7-HA subunits and the ER sub-
compartment labeled with DsRed-ER were better resolved than endogenous α7 subunits (Fig
8E). We determined the degree of colocalization and the coefficients of colocalization, R, and
found that α7 subunits and Ric-3 in dendrites were highly co-localized with the ER sub-
compartment as was observed with endogenous Ric-3. 83% of the ER marker pixels co-
localized with α7 subunits (R = 0.74 ± 0.03, n=10 neurons) and 80% with CFP-Ric-3 (R = 0.67
± 0.04, n=12 neurons) indicating strong co-localization. There was also strong co-localization
between α7 and CFP-Ric-3 (R = 0.71 ± 0.04, n=13 neurons). When we stained for intracellular
BgtRs, we observed two distributions of Fl-Bgt staining in the somata similar to what we
observed in HEK and PC12 cells: a diffuse pool that co-localized with CFP-Ric-3 and bright
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Fl-Bgt puncta (Fig. 8F). In the dendrites, we clearly resolved two different types of staining
that contained α7 subunits. The first type contained α7-HA subunits, CFP-Ric-3, DsRed-ER
and either no staining or light staining with Fl-Bgt (Figs. 8E,G). This type of staining, while
generally diffuse and reticulated as in the somata, also consisted of smaller puncta (see Fig.
8H). The second type of α7 subunit structures in dendrites, while fewer in number than the first
type, contained Fl-Bgt at higher intensity but no Ric-3 or DsRed-ER (Fig. 8G). These structures
were similar in appearance to the Fl-Bgt transport vesicles found in the somata (Fig. 8F). We
often observed these structures in close apposition to ER sub-compartment membranes that
contained Ric-3 (Fig. 8I) and α7 subunits (data not shown), which suggested that the BgtR
containing puncta budded from the ER sub-compartment membranes.
Why do Ric-3 and α7 subunits co-localize to the ER sub-compartment of dendrites? One
possibility is that Ric-3 and/or α7 subunit mRNA are transported to sites in dendrites where
they are translated via local protein synthesis (Martin and Zukin, 2006) and synthesized at the
ER sub-compartment. To test for this, we transfected cultured neurons with different
combinations of the plasmids for CFP-Ric-3, HA-tagged α7 subunits (α7-HA) and the ER
marker, DsRed-ER, which co-localizes well with the dendritic ER sub-compartment (Bannai
et al., 2004). Previous studies of transfected α7 subunits (Xu et al., 2006) and DsRed-ER
(Bannai et al., 2004) found that their basic properties in terms of their expected distribution in
the neurons were not altered. Virtually all of the transfected CFP-Ric-3, α7-HA subunits and
DsRed-ER appeared first in the somata before we observed their staining in the dendrites (data
not shown). This finding does not rule out the possibility that some local dendritic synthesis
is occurring but does indicate that the bulk of these proteins is synthesized in the somatic ER
and then transported out to the dendrites.
Another possible explanation for why Ric-3 and α7 subunits co-localize to the ER sub-
compartment of dendrites is that ER sub-compartment is the compartment in which α7 subunits
are trafficked along dendrites. The ER sub-compartment in dendrites has a dedicated transport
system composed of small vesicles that traffic proteins synthesized in the somatic ER to the
dendritic ER sub-compartment (Bannai et al., 2004; Mironov and Symonchuk, 2006). NMDA-
type glutamate receptors (NMDARs) are trafficked via this pathway and bypass the Golgi in
somata if associated with SAP97 (Jeyifous et al., 2009). Thus, Ric-3 could play a similar role
as SAP97 and α7 subunits could be trafficked from the ER in the soma via the ER sub-
compartment in dendrites.when associated with Ric-3. To test for this possibility, we performed
additional experiments to determine whether α7 subunits, when complexed with Ric-3, are
trafficked from the ER in the soma via the ER sub-compartment in dendrites. If Ric-3 is
synthesized in the somatic ER and trafficked to dendrites via the ER sub-compartment, we
would predict that Ric-3, which is highly co-localized with α7 subunits in dendrites, should be
observed in rapidly moving puncta (0.2–0.3 µm/sec; see (Bannai et al., 2004)). We would also
predict that the Ric-3 puncta should contain ER markers as previously observed (Bannai et al.,
2004). To test these predictions, we performed time-lapse, live-imaging of neurons transfected
with CFP-Ric-3 and the fluorescent ER marker DsRed-ER. A large number of the puncta
containing both constructs was seen rapidly moving (0.22 ± 0.04 µm/sec, n=17 puncta) as
shown in Fig. 8H. The high degree of colocalization between CFP-Ric-3, ER-DsRed and
α7HA immunostaining strongly suggests that the moving CFP-Ric-3 and ER-DsRed puncta
contain α7 subunits consistent with their transport via the ER sub-compartment. Another
prediction is that changes in Ric-3 levels in the neurons should alter the trafficking of α7
subunits from the soma to dendrites. Ric-3 knockdown experiments would be difficult to
interpret because at levels below detection by immunoblotting and immunofluorescence (Figs.
1 and 2) Ric-3 promotes BgtR assembly and release from the ER.
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Discussion
In this study, we addressed how Ric-3 functions with respect to α7 subunits. The initial genetic
screen and characterization of Ric-3 mutations in C. elegans indicated that Ric-3 had a role in
nAChR assembly and/or trafficking (Halevi et al., 2002). The introduction of Ric-3 into
cultured mammalian cells or Xenopus oocytes altered cell-surface and total expression of 5HT3
receptors and different nicotinic receptor subtypes but not other receptors such as AMPA
receptors (Halevi et al., 2002; Halevi et al., 2003; Castillo et al., 2005). Ric-3 either promoted
(Cheng et al., 2005; Cheng et al., 2007) or inhibited (Halevi et al., 2003) 5HT3A receptor
surface levels. Results co-expressing Ric-3 with α4β2 nAChRs were also inconsistent. One
study found that Ric-3 decreased whole-cell currents (Halevi et al., 2003) and another found
that Ric-3 increased whole-cell epibatidine binding to nAChRs (Lansdell et al., 2005). The
introduction of Ric-3 consistently enhanced surface expression of α7-containing BgtRs in a
variety of expression systems (Halevi et al., 2002; Halevi et al., 2003; Ben-Ami et al., 2005;
Castillo et al., 2005; Lansdell et al., 2005; Williams et al., 2005; Castillo et al., 2006; Wang et
al., 2009), though the degree of the enhancement was variable. These discrepancies can be
explained by our findings that Ric-3’s function changes dependent on Ric-3 levels. In cases
where the number of cell-surface receptors increased, our data indicate that Ric-3 levels were
low enough that Ric-3 increased BgtR formation and ER release. In cases with decreased cell-
surface expression, levels of Ric-3 high enough to cause receptor ER retention explain the
results. In all studies, surface expression of α7-containing BgtRs was enhanced by Ric-3
because the number of surface BgtRs was not significant in the absence of Ric-3. Thus, even
at the highest Ric-3 levels there was a net increase in the number of surface α7-containing
BgtRs (Fig. 1A).
Differences were also reported in studies examining where Ric-3 resides in cells. Most studies
found Ric-3 predominantly in the ER (Castillo et al., 2005; Cheng et al., 2005; Cheng et al.,
2007; Wang et al., 2009), where it is synthesized. However, Ric-3 has also been reported to
co-localize with nAChRs at the cell surface (Williams et al., 2005) and in the Golgi apparatus
(Castillo et al., 2005; Cheng et al., 2007). When we transfected low levels of Ric-3 into HEK
cells, Ric-3 co-localized with markers of the ER but did not co-localize with markers of the
Golgi apparatus or at the cell surface. Similar results were obtained for endogenous Ric-3 in
PC12 cells and cultured neurons. In these cells, native Ric-3 again was localized to the ER and
not to the Golgi apparatus or cell-surface. In neurons, the localization in the ER extended from
the soma into the dendrites where we observed that Ric-3 trafficked in transport vesicles. These
vesicles appeared to be a part of the ER sub-compartment of dendrites (Spacek and Harris,
1997; Toresson and Grant, 2005) and did not localize to “Golgi outposts” or the cell surface.
Although we only found Ric-3 in the ER, it is still possible that Ric-3 traffics out of the ER to
other compartments in the secretory pathway, but such departures must be rapid under normal
circumstances.
We initially thought that the ER retention of α7 and α7/5HT3 subunits observed at high Ric-3
levels in HEK cells was an artifact caused by over-expression. We based this conclusion on
the correlation between ER retention and aggregation and the finding that aggregation was not
observed for endogenous Ric-3 in PC12 cells and neurons. As discussed in more detail below,
subsequent observations suggested that native Ric-3 in cultured neurons can act to retain α7
subunits in the ER and this retention occurs without aggregates forming. The lack of Ric-3
aggregates in the neurons indicates that it is the “non-aggregated” or “free” Ric-3 that mediates
subunit ER retention. ER retention of the subunits appears to result from a change in the nature
of the interaction between Ric-3 and the subunits transitioning from a transient, short-lived
interaction at low levels of Ric-3 to a more stable, long-lived interaction at higher levels. This
is suggested by the ability to co-immunoprecipitate Ric-3 and the subunits at the higher Ric-3
levels and the extremely low levels of Ric-3 that increased BgtR formation and trafficking to
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the surface (Fig. 1). Because Ric-3 is apparently an ER resident protein, long-lived interactions
with Ric-3 could act to prevent interactions with COPII complex proteins that mediate release
of membrane proteins from the ER. Ric-3 aggregates would form as Ric-3-subunit complexes
accumulate in the ER and may involve a loss of ER-associated degradation (ERAD). The large
aggregated Ric-3 structures we observed outside the ER of HEK cells with or without the
subunits have the appearance of autophagosomes that can form when ERAD is overwhelmed
and somehow depart the ER (e.g. (Kruse et al., 2006)).
Ric-3 trafficked differently in neurons than in PC12 or HEK cells. In cultured neurons, Ric-3
along with α7 subunits moved rapidly in puncta with the features of transport vesicles
previously found to be part of the ER sub-compartment in dendrites (Bannai et al., 2004). Ric-3-
containing puncta were not observed in PC12 or HEK cells and Ric-3 was clearly absent from
the α7 subunit-containing puncta stained by Fl-Bgt that appeared to be transporting mature
BgtRs to the surface of PC12 and HEK cells. Bgt-stained puncta that lacked Ric-3 were also
present in the somata and dendrites of neurons. Our finding that significantly higher levels of
native Ric-3 in the somata of neurons than in PC12 cells together with the co-localization of
Ric-3 and α7 subunits in moving puncta that are part of the ER sub-compartment of dendrites
suggests that the events depicted in Fig. 9 are occurring in neurons. In the model, Ric-3 has
two separate functions regulated by the levels of Ric-3 available to interact with α7 subunits.
At low levels (Fig. 9A and C), Ric-3 acts only to mediate BgtR folding and assembly. This
appears to be how Ric-3 functions in PC12 cells and also in neurons when BgtRs are released
from the ER in the soma and traffic via the somatic Golgi to the cell membrane. At higher
levels in neurons, Ric-3 retains α7 subunits in the ER in addition to mediating BgtR folding
and assembly (Fig. 9B). When restricted to the ER, complexes of Ric-3 and α7 subunits together
remain within the ER sub-compartment and are transported on moving puncta in dendrites
(Fig. 9C, red arrow pathway). We recently determined that NMDA-type glutamate receptors
(NMDARs) in hippocampal neurons are also trafficked through such an “ER-restricted”
pathway in dendrites (Jeyifous et al., 2009). Transport of NMDARs through the ER sub-
compartment requires the presence of SAP97, which associate specifically with NMDAR
NR2B subunits and, like Ric-3, acts to retain its binding partner in the ER of HEK cells. Thus,
Ric-3 may have a role similar to SAP97 in retaining its binding partner in the ER sub-
compartment. In neurons, the “ER-restricted” pathway taken by NMDARs sorts NMDARs
from AMPA-type glutamate receptors, which are trafficked through the conventional secretory
pathway in the soma (Jeyifous et al., 2009). After departing the ER sub-compartment, NMDA
receptors traffic through Golgi outpost near spines (Jeyifous et al., 2009). Similarly, we assume
that BgtRs are released from the ER sub-compartment and traffic through Golgi outposts before
inserting in the plasma membrane (Fig. 9C). Consistent with this idea are the BgtR-containing
puncta we observed in close opposition to the ER sub-compartment membranes in the dendrites
(Fig. 8I). These puncta may traffic via Golgi outposts to the dendritic surface after release from
the ER sub-compartment membranes.
As shown previously (Kawai et al., 2002; Xu et al., 2006), BgtRs are found on the somata and
dendrites of cultured hippocampal neurons and do not traffic to axons. However, there is much
evidence that BgtRs do traffic to axons in vivo and, in particular, to axon terminals where their
activation can regulate the presynaptic release of neurotransmitters (Gray et al., 1996; Fabian-
Fine et al., 2001). In cultured hippocampal neurons, BgtR axonal transport may be prevented
in part by the relatively high levels of Ric-3 that restrict α7 subunits to the dendritic ER sub-
compartment. If true, mechanisms should exist to regulate Ric-3 levels in cells. Recent work
indicates that levels of Ric-3 are tightly regulated by the ubiquitin proteosome system in C.
Elegans (Shteingauz et al., 2009). Mechanisms may also exist that regulate Ric-3 interactions
with α7 subunits, thereby determining when BgtR is released from the ER sub-compartment
in dendrites. An example of other membrane proteins regulated this way is the ER-retention
of the proteins that mediate cholesterol homeostasis. The release of HMG CoA reductase and
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other proteins involved in cholesterol homeostasis from the ER is regulated by sterol levels
(Espenshade and Hughes, 2007; Sun et al., 2007). Ric-3 and the proteins that regulate α7
subunit assembly and trafficking may have a similar role to the proteins SCAP and Insig-1 and
−2 that regulate HMG CoA reductase and sterol regulatory element binding protein assembly
and trafficking.
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Figure 1. The dependence of BgtR expression on Ric-3 levels
Surface and internal BgtR expression were assayed by 125I-Bgt binding, which is displayed as
pmol 125I-Bgt per mg total cellular protein. 125I-Bgt binding assays were performed using
transiently transfected HEK cells with set amounts of α7 (A) or α7/5HT3A (B) subunits (5 µg
plasmid) and varying amounts of Ric-3 plasmid as shown. (C) Immunoblots and quantification
of FLAG-tagged Ric-3 protein levels at the indicated plasmid levels. (D) Displayed is the cell-
surface to total ratio of 125I-Bgt binding sites.
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Figure 2. The cellular distribution of BgtRs and Ric-3 at different Ric-3 levels
We used flow cytometry to isolate representative cells for immunofluorescence analysis. To
identify cells expressing BgtRs and different levels of Ric-3, cells were sorted using surface
Fl-Bgt fluorescence and CFP or CFP-Ric-3 fluorescence. We performed three separate
transfections each with a set amount of α7 subunit plasmid and varying amounts of Ric-3
plasmid: (A–C) No Ric-3, where α7 subunit expression was monitored using co-transfection
with a CFP plasmid (pECFP); (D–F) low Ric-3 (0.01 µg CFP-Ric-3 plasmid) or (G–I) high
Ric-3 (0.1 µg CFP-Ric3 and 4.9 µg Ric-3 plasmids). In panels A, D, and G, surface BgtRs
were labeled with Fl-Bgt and points on the graphs represent single-cell fluorescence values for
CFP or CFP-Ric-3 (x-axis) and Fl-Bgt (y-axis). The grey areas represent the level of non-
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specific Fl-Bgt staining and/or autofluorescence of sham transfected cells. The horizontal line
in each panel marks the maximum level of non-specific Fl-Bgt staining of sham transfected
cells. In A, cells expressing α7 subunits without Ric-3 were selected (boxed group, CFP+) only
using CFP fluorescence because there was no significant Fl-Bgt fluorescence. In D, cells
expressing significant amounts of surface BgtRs were selected (boxed group, Fl-Bgt+) only
using Fl-Bgt because there was no significant CFP-Ric-3 fluorescence at the low Ric-3 levels.
In G, cells expressing high Ric-3 levels without surface BgtRs were selected (boxed group,
Fl-Bgt-/CFP-Ric-3+) using CFP-Ric-3 fluorescence and an absence of any significant Fl-Bgt
fluorescence. In the other panels are displayed examples of sorted cells typical of the three
different transfections. In B, E and H are the following four images of the same cell set: 1) cell
surface BgtRs labeled with Fl-Bgt are displayed (upper right), 2) CFP or CFP-Ric-3 (upper
left), DIC (lower left) and 4) merged image of 1 and 2 (lower right). The boxed area in E, lower
right is magnified in the inset to show the lack of overlap between surface BgtRs and CFP-
Ric-3. The boxed area in H, upper left is magnified in the inset to show the features of the
Ric-3 aggregates. In C, F, and I, are the following two images of the same cell set: 1) CFP or
CFP-Ric-3 (upper) and 2) all α7 subunits labeled with anti-α7 Abs. Scale bars, 10 µm.
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Figure 3. Effect of Ric-3 mediated on ACh-evoked currents of BgtRs
We performed whole-cell patch clamp recordings on cells expressing α7 subunits and no Ric-3,
low levels of Ric-3 and high levels of Ric-3 as in Fig. 2. Cells were sorted as in Fig. 2 for CFP
fluorescence (CFP+), Fl-Bgt fluorescence (Fl-Bgt+) or for Ric-3 fluorescence and no Fl-Bgt
fluorescence (Fl-Bgt-/CFP-Ric-3+). Displayed are mean current amplitudes in response to the
application of saturating ACh (1 mM) for cells sorted by CFP fluorescence expressing α7 and
no Ric-3 (n=16), cells sorted by Fl-Bgt fluorescence with low levels of Ric-3 (n=28), or high
levels of Ric-3 (n=15) when compared to sham transfected cells (n=5). A current response
recorded after application of saturating ACh (1 mM; denoted by line above the current trace)
is displayed in the inset. The spikes corresponding to the beginning and end of ACh application
were artifacts caused by opening and closing of the solenoid valve. Cells sorted by having a
significant amount of Fl-Bgt fluorescence had significantly higher current amplitudes than α7
expressing cells with no Ric-3 (p<0.05). Cells transfected with high amounts of Ric-3 had
significantly smaller current amplitudes than those cells transfected with low amounts of Ric-3
(p<0.05). There were no ACh-evoked currents from sham transfected cells or cells sorted with
no significant Fl-Bgt fluorescence and high levels of Ric-3 (n=6) and only one cell sorted with
no significant Fl-Bgt fluorescence and low levels of Ric-3 exhibited a current response (n=5).
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Figure 4. Cellular localization of Ric-3 in the absence of α7 subunits
Cells expressing low or high levels of Ric-3 without α7 subunits were sorted as in Fig. 2.
(A) Sorted cells with low levels of Ric-3 were stained with Abs specific for an ER marker (anti-
PDI) and a Golgi marker (anti-GM-130). (B and C) Merged images of the cells from A showing
the degree of co-localization between CFP-Ric-3 and the ER marker (B) or Golgi marker
(C). To the right are enlarged views of the boxed regions in the panels. (D) Sorted cells with
high levels of Ric-3 were stained with Abs specific for an ER marker (anti-PDI) and a Golgi
marker (anti-GM-130). (E and F) Merged images of the cells from E showing the degree of
co-localization between CFP-Ric-3 and the ER marker (E) or Golgi marker (F). To the right
are enlarged views of the boxed regions in the panels. Scale bars, 10 µm.
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Figure 5. Cellular localization of Ric-3 and α7 subunits
As in Fig. 2, cells expressing α7 subunits and no Ric-3 (A and B), low levels of Ric-3 (C and
D) and high levels of Ric-3 (E and F) were sorted. Images of typical cells are displayed for the
different levels of Ric-3. The left half of each panel is divided into four sections: 1) the CFP
fluor used for sorting (upper left), 2) the ER marker (anti-PDI Ab; upper right), 3) the α7
subunit-specific marker (anti-α7 Ab or Fl-Bgt; lower left) and 4) the DIC image (lower right).
On the right half are merged images of 2 and 3. (A) Cells were stained for α7 subunits and the
ER. (B) Cells were stained for intracellular BgtRs and the ER. (C) Cells were stained for α7
subunits and the ER. A higher magnification of the boxed region in the merged image is
displayed in the inset and is a merged image of the CFP-Ric-3 and anti-α7 Ab fluorescence.
(D) Cells were stained for intracellular BgtRs and the ER. With low Ric-3 levels, we observed
bright puncta stained with Fl-Bgt. A higher magnification of the puncta in the boxed region in
the merged image is displayed in the inset and is a merged image of the CFP-Ric-3 and Fl-Bgt
fluorescence. (E) Cells were stained for α7 subunits and the ER marker. With high Ric-3 levels,
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we observed Ric-3 aggregates stained with anti-α7 and Fl-Bgt. A higher magnification of the
boxed region in the merged image is displayed in the inset and is a merged image of the CFP-
Ric-3 and anti-α7 Ab fluorescence. (F) Cells were stained for intracellular BgtRs and the ER.
(G) Cells were sorted and stained as in D or F and we determined the percent of sorted cells
that had 4 or more Fl-Bgt-stained puncta. On the Y axis we plotted the percent of total cells
with 4 or more Fl-Bgt-stained puncta at the indicated levels of Ric-3 for cells sorted for Fl-Bgt
fluorescence (Fl-Bgt+) or for cells lacking Fl-Bgt fluorescence but positive for CFP-Ric-3
fluorescence (Fl-Bgt-/CFP-Ric-3+). Scale bars, 5 µm.
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Figure 6. Native Ric-3 in PC12 cells
(A) PC12 cells were immunostained with Abs specific for Ric-3 (left) and anti-α7 subunits
(right). (B) Relation between intracellular and surface BgtR levels as determined by Fl-Bgt
labeling (Y-axis) and Ric-3 levels as determined by staining with Ric-3-specific Abs (X-axis).
(C) PC12 cells were labeled with Fl-Bgt on the cell surface, permeabilized, then stained using
the anti-Ric-3 Ab. (D) Staining with anti-Ric-3, anti-α7, and anti-PDI (ER marker) Abs. (E)
Intracellular Fl-Bgt staining of PC12 cells together with anti-Ric-3 and anti-PDI (ER marker)
Ab staining. Scale bars, 5 µm.
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Figure 7. Native Ric-3 and α7 subunits in hippocampal neurons
Cultured hippocampal neurons (18 to 24 days in-vitro) were stained to examine the distribution
of Ric-3, α7 subunits, Bgt binding sites, and ER structures. (A) Cultured neurons were stained
with Fl-Bgt to internal sites (upper left), anti-GAD Ab (upper right) and anti-Ric-3 Ab (lower
left). Stained nuclei are overlaid with a DIC image in the lower right panel. (B) Cultured
neurons were stained with anti-Ric-3 Ab (upper left), anti-MAP2 Ab (upper right) and anti-
neurofilament heavy chain (NFH) Ab (lower left). The merged image is in the lower right
panel. (C) Somata were stained with anti-Ric-3 Ab (left) and the ER marker (anti-PDI Ab;
middle). The merged image is in the right panel. (D) Somata were stained with anti-Ric-3 Ab
(left) and anti-α7 Ab (middle). The merged image is in the right panel. (E) Somata stained with
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anti-Ric-3 Ab (left) and stained with Fl-Bgt to internal sites (middle). The merged image is in
the right panel. Examples of bright Fl-Bgt stained puncta are highlighted in the box and
magnified in the inset. (F) Dendrites were stained with anti-Ric-3 Ab (top) and the ER marker
(anti-PDI Ab; middle). The merged image is in the bottom panel. (G) Dendrites were stained
with anti-Ric-3 Ab (top) and anti-α7 Abs (middle). The merged image is in the bottom panel.
(H) Dendrites were stained with anti-Ric-3 Ab (top) and with Fl-Bgt to internal sites (middle).
The merged image is in the bottom panel. Scale bars, 50 µm (A, B) and 5 µm (C–E, G–I).
Alexander et al. Page 29
J Neurosci. Author manuscript; available in PMC 2011 January 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 8. Transfected Ric-3 and α7 subunits in hippocampal neurons
Cultured hippocampal neurons transfected with the CFP-Ric-3, DsRed-ER, and epitope-tagged
α7 constructs. (A) Somata imaged for CFP-Ric-3 (top) and the ER marker, DsRed-ER (middle).
The merged image is in the bottom panel. On the left of each panel is a soma transfected with
low levels of CFP-Ric-3 and on the right with high levels of CFP-Ric-3. (B) Transfected
neurons imaged for CFP-Ric-3 (upper left), anti-MAP2 Ab (upper right) and anti-NFH Ab
(lower left). The merged image is in the lower right panel. Image contrast has been enhanced
to show distribution of CFP-Ric-3 in dendrites, which results in over-exposed somata. (C)
Transfected neurons imaged for CFP-Ric-3 (upper left) and surface FL-Bgt (upper right). The
merged image is in the lower right and the DIC image in lower left panel. (D) A soma from a
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transfected neuron imaged for CFP-Ric-3 (upper left), DsRed-ER (upper middle) and α7-HA
subunits (lower left). The corresponding merged images are in the upper right, lower middle
and lower right panels as indicated. (E) A dendrite from a transfected neuron imaged for CFP-
Ric-3 (top), DsRed-ER (2nd from top) and α7-HA subunits (middle). Merged images are in the
two bottom panels as indicated. (F) A soma from a transfected neuron imaged for CFP-Ric-3
(left) and internal Fl-Bgt (middle). DsRed-ER (upper middle) and α7-HA subunits (lower left).
The merged image is in the right panel. (G) A dendrite from a transfected neuron imaged for
CFP-Ric-3 (top) and internal Fl-Bgt (middle). The merged image is in the bottom panel. (H)
Time lapse images of CFP-Ric-3 and ER-DsRed transfected neurons showing an example of
a fast moving puncta (large arrow heads) and static structures (small arrow heads) that contain
both CFP-Ric-3 and ER-DsRed. The asterisk denotes the start location of the moving puncta.
Images acquired alternated between the CFP channel and the DsRed channel with 2.5 seconds
between acquisitions, starting with CFP-Ric-3 at time 0. (I) Top: An example of an ER sub-
compartment structure imaged with CFP-Ric-3 (right) and a bright internal Fl-Bgt stained
puncta (middle) in a dendrite. The merged image is in the right panel. Top: A line profile
analysis of the Fl-Bgt (red) and CFP-Ric-3 (green) structures illustrating the Fl-Bgt puncta
juxtaposed to the CFP-Ric-3 structure. Scale bars, 10 µm (A–C) and 5 µm (D–H).
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Figure 9. Model of how Ric-3 function is altered by changes in Ric-3 levels in neurons
(A) At low levels, Ric-3 interactions with α7 subunits are short-lived and mediate BgtR
assembly and release from the ER. (B) At higher levels, Ric-3 interactions with α7 subunits
are long-lived and retain BgtRs in the ER in addition to promoting BgtR assembly. (C) The
BgtR trafficking pathway is determined by the type of Ric-3 interaction with α7 subunits. At
low levels, short-lived interactions with Ric-3 result in ER release of BgtRs in the soma and
BgtRs traffic through the conventional secretory pathway through the ERGIC compartment
and Golgi apparatus in the soma to the plasma membrane (blue arrow pathway). At high levels,
long-lived interactions with Ric-3 result in ER retention of BgtRs in the soma and BgtRs traffic
through the atypical secretory pathway in transport vesicles that are part of the the ER sub-
compartment in dendrites to Golgi outposts and then to the plasma membrane in dendrites (red
arrow pathway).
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Table 1
Distribution of Ric-3, α7 and GAD in cultured hippocampal neurons
Ab epitope Anti-GAD Anti-Ric-3 Anti-α7
% of total neurons 12 ± 2% (1279 neurons) 17 ± 0.7% (1129 neurons) 16 ± 1% (833 neurons)
% of GAD+ neurons 100% 92 ± 3% (126 neurons) 90 ± 8% (89 neurons)
% of Ric-3+ neurons 84 ± 3% (140 neurons) 100% 92 ± 5% (87 neurons)
% of α7+ neurons 79 ± 6% (107 neurons) 97 ± 2% (81 neurons) 100%
n=3 experiments
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